Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.074x

Based on the latest financial reports, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has a cash flow conversion efficiency ratio of 0.074x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥502.01 Million ≈ $73.46 Million USD) by net assets (CN¥6.75 Billion ≈ $987.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review 603707 FCF to total liabilities ratio to assess the company's free cash flow relative to its total liabilities.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see how much is Nanjing King-friend Biochemical Pharmace worth for the company's overall valuation and market capitalisation.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanjing King-friend Biochemical Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ATS CORP TO:ATS	0.064x
Nurix Therapeutics Inc NASDAQ:NRIX	-0.154x
Luenmei Quantum Co Ltd SHG:600167	0.009x
Douglas Emmett Inc NYSE:DEI	0.034x
Scandic Hotels Group AB (publ) ST:SHOT	0.337x
Aluar Aluminio Argentino BA:ALUA	0.051x
Ningbo Shuanglin Auto Parts SHE:300100	0.079x
Taihai Manoir Nuclear Equipment Co Ltd SHE:002366	-0.016x

Annual Cash Flow Conversion Efficiency for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2025. View Nanjing King-friend Biochemical Pharmace share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.90 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $173.08 Million	0.171x	-25.91%
2024-12-31	CN¥6.49 Billion ≈ $949.42 Million	CN¥1.50 Billion ≈ $219.68 Million	0.231x	-17.14%
2023-12-31	CN¥5.80 Billion ≈ $848.50 Million	CN¥1.62 Billion ≈ $236.94 Million	0.279x	+189.21%
2022-12-31	CN¥6.17 Billion ≈ $902.45 Million	CN¥595.45 Million ≈ $87.13 Million	0.097x	-23.70%
2021-12-31	CN¥5.40 Billion ≈ $790.59 Million	CN¥683.63 Million ≈ $100.04 Million	0.127x	+183.74%
2020-12-31	CN¥3.74 Billion ≈ $547.95 Million	CN¥-565.85 Million ≈ $-82.80 Million	-0.151x	+46.05%
2019-12-31	CN¥3.00 Billion ≈ $439.59 Million	CN¥-841.38 Million ≈ $-123.12 Million	-0.280x	-1187.25%
2018-12-31	CN¥2.42 Billion ≈ $354.28 Million	CN¥62.37 Million ≈ $9.13 Million	0.026x	+122.54%
2017-12-31	CN¥2.05 Billion ≈ $300.31 Million	CN¥-234.59 Million ≈ $-34.33 Million	-0.114x	+47.60%
2016-12-31	CN¥1.31 Billion ≈ $192.37 Million	CN¥-286.79 Million ≈ $-41.97 Million	-0.218x	-273.64%
2015-12-31	CN¥1.09 Billion ≈ $159.89 Million	CN¥137.28 Million ≈ $20.09 Million	0.126x	-27.47%
2014-12-31	CN¥1.03 Billion ≈ $150.99 Million	CN¥178.74 Million ≈ $26.16 Million	0.173x	-9.03%
2013-12-31	CN¥1.02 Billion ≈ $149.02 Million	CN¥193.91 Million ≈ $28.38 Million	0.190x	--

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.93 Billion

CN¥13.18 Billion CNY

Market Cap Rank

#6306 Global

#1267 in China

Share Price

CN¥8.16

Change (1 day)

+0.74%

52-Week Range

CN¥6.84 - CN¥11.76

All Time High

CN¥33.62